Industry: Healthcare Technology

Amptify

Origin: MO | Grant Awarded: 2017 | Status: Active

Visit Website →

What is Amptify?

Amptify is a full-stack hearing healthcare platform that offers an ecosystem of solutions built to improve the provider and patient experience through digital-first care.

With its technology platform, Amptify engages in the provision and facilitation of hearing healthcare products and services via mobile devices, the internet, video and phone. Founded in 2015 by a world-renowned aural rehabilitation research team as a university spin-off from the Audiovisual Speech Perception Laboratory at the Washington University in St. Louis School of Medicine, Amptify is a global leader in comprehensive hearing healthcare, offering technology to connect, expertise clients and patients can trust, and the power to improve hearing healthcare for all.

Company Leadership

Nancy Tye-Murray

Founder & chief science officer

Dr. Tye-Murray is a Professor of Audiology at Washington University in St. Louis and the founder of Amptify.

Connect on LinkedIn →

Brent Spehar

Dr. Spehar is an audiologist and research scientist at Washington University in St. Louis and the co-founder of Aptify.

Chris Cardinal

CeO

Chris Cardinal is an entrepreneurial-minded executive with a successful history of driving corporate strategy through effective product and process management. Mr. Cardinal is the President and COO of Amptify, is a Member of the Consumer Technology Association’s Digital Therapeutic working group, is a Mentor at Sling Health and at ITEN. Formerly, Mr. Cardinal served as the SVP of Product at SensorRX and was Co-Founder and CEO of the digital health company Welltodo which was successfully acquired in Q3 of 2018. Prior, he also served as an EIR at the Regnier Institute of Entrepreneurship and Innovation and as Managing Partner of the strategic management and business planning firm Huddle Strategic.

Tad Zelski

Mr. Zelski was formerly the Director of Professional Development at Widex Hearing Aid Manufacturing, in which capacity he helped audiological practices develop service delivery models.

Steven Tye

Mr. Tye is a former investment banker and has created several web-based services and businesses that promote good health. Mr. Tye serves as Ampitfy’s Director of Finance.

Involved Industries

Explore All Startups

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.

LEARN ABOUT THE COMPETITION
See How You Can Get Involved →

Geneoscopy

Origin: MO | Grant Awarded: 2016 | Status: Active

Visit Website →

What is Geneoscopy?

Geneoscopy is the developer of next-generation diagnostics designed to treat digestive diseases and offer cancer screening. The company’s diagnostics help in consistently extracting stool-derived eukaryotic RNA (seRNA) transcripts and detecting changes in gene expression, enabling doctors to better prevent, detect, and guide treatment for gastrointestinal disease.

Company Leadership

Erica Barnell

Chief Scientific Officer

Geneoscopy co-founder, Erica Barnell graduated from Cornell University with a dual degree in Biological Sciences and Applied Economics & Management. Erica is an MD/PhD candidate at the Washington University School of Medicine. In 2019, Erica completed her PhD at the McDonnell Genome Institute. Her thesis work surrounded the development of bioinformatic tools to alleviate the analysis bottleneck within precision oncology. Erica has published 19 peer-reviewed manuscripts, 11 abstracts with 4 platform presentations, and two book chapters within the oncology space. Erica conducted the original research to validate Geneoscopy’s stool extraction method and managed all feasibility studies for Geneoscopy’s colorectal cancer (CRC) screening test. Erica was responsible for existing engagement with the FDA, which includes holding three presubmission meetings and obtaining Breakthrough Device Designation for the lead CRC screening test. Erica is the lead inventor on all patents pertaining to Geneoscopy’s technology and is currently the site investigator on two IRB-approved protocols.

Connect on LinkedIn →

Andrew Barnell

Chief executive Officer

Co-founder of Geneoscopy, Andrew graduated from Cornell University with a Bachelor’s degree in Applied Economics & Management and a specialization in Finance. He received an MBA in Health Care Management and Entrepreneurial Management from The Wharton School. Andrew began his career as a financial analyst in J.P. Morgan’s healthcare investment banking group, working primarily on M&A and capital markets transactions. Andrew also worked as an associate at Lindsay Goldberg, a middle-market private equity firm focused on partnering with family-owned businesses.

Connect on LinkedIn →

Involved Industries

Explore All Startups

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.

LEARN ABOUT THE COMPETITION
See How You Can Get Involved →

Artera

Origin: CA | Grant Awarded: 2016 | Status: Active

Visit Website →

What is Artera?

Artera developed WELL, a trusted communication platform that connects patients to healthcare organizations via text, phone, email, and live-chat. The platform provides the most efficient and effective way for healthcare administration to interact with patients between visits.

Company Leadership

Giulluame de Zwirek

Chief Executive Officer

Gui has a B.S. in Business Administration and a B.A. in Classical Guitar Performance from the University of Southern California, as well as a Preparatory Degree in Classical Guitar from the San Francisco Conservatory of Music. Gui was previously the Product Marketing Manager at Google and the Director of Publishing & Performance Marketing at Graphiq.com.

Connect on LinkedIn →

Involved Industries

Explore All Startups

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.

LEARN ABOUT THE COMPETITION
See How You Can Get Involved →

HIPAAtrek

Origin: MO | Grant Awarded: 2015 | Status: Active

Visit Website →

What is HIPAAtrek?

HIPAAtrek’s cloud-based software guides healthcare organizations and third-party companies to create, implement, and maintain a customizable HIPAA compliance program.

Company Leadership

Sarah Badahman

Chief Executive Officer

Sarah earned her degree in Mathematics and Historical Studies from Southern Illinois University at Edwardsville in 2005, and holds an MPH from Benedictine University. Before joining HIPAAtrek, Sarah worked with Symvato, LLC and Midwest Nephrology & Hypertension Associates and is a Certified HIPAA Privacy and Security Expert.

Connect on LinkedIn →

Involved Industries

Explore All Startups

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.

LEARN ABOUT THE COMPETITION
See How You Can Get Involved →

Graematter

Origin: MO | Grant Awarded: 2012 | Status: Active

Visit Website →

What is Graematter?

Graematter developed a regulatory intelligence system that makes it easier to access and analyze regulatory information. They integrate data from a number of FDA-related databases and data sources into a single database that provides advanced search capabilities.

Company Leadership

Melissa Walker

President and Chief Technology Officer

Melissa earned her BSMS degree in Biology, Animal Science, and Zoology from East Texas State University in 1979. Melissa is a regulatory professional with over 27 years of experience in the medical products industry. She has served as the industry representative for the FDA Medical Device Dispute Advisory Panel and is an Adjunct Professor at Washington University in St. Louis. Melissa also currently serves as the Senior Vice President for Regulatory Affairs at Topera.

Connect on LinkedIn →

Merle Symes

Chief Executive Officer

Merle earned his degree in Chemical Engineering from South Dakota School of Mines and Technology in 1973, and holds an MBA from the Wharton School at the University of Pennsylvania. Merle brings experience working with The Provenance Group, and as the Managing Director of The Walden Group. He also currently serves on the Board of Shalom House for Homeless Women.

Connect on LinkedIn →

Involved Industries

Explore All Startups

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.

LEARN ABOUT THE COMPETITION
See How You Can Get Involved →